Skip to main content
Kukje Pharma Co., Ltd. logo

Kukje Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 002720 ISIN · KR7002720001 KO Manufacturing
Open in API
Filings indexed 299 across all filing types
Latest filing 2020-03-20 Board/Management Inform…
Country KR South Korea
Listing KO 002720

About Kukje Pharma Co., Ltd.

https://www.kukjepharm.co.kr/index.php?…

Kukje Pharma Co., Ltd. is a company engaged in the manufacturing, distribution, import, and export of pharmaceutical products, cosmetics, and health supplements. Its core offerings include a wide range of prescription (ETC) and over-the-counter (OTC) drugs, with a notable specialization in antibiotics such as Cephalosporins. In addition to its primary pharmaceutical business, the company also develops and markets cosmetic products, food supplements, and respiratory protection face masks. The company serves both domestic and international markets.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). This is a standard corporate governance disclosure regarding changes to the board of directors. According to the provided definitions, announcements regarding changes in the board of directors fall under the 'Board/Management Information' (MANG) category.
2020-03-20 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 95% confidence The document is a regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment or dismissal of an outside director. This falls under the category of board management changes, specifically the 'Board/Management Information' (MANG) category, as it details changes to the company's board composition.
2020-03-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when an executive or major shareholder changes their shareholding position. This falls under the category of 'Director's Dealing' (DIRS), which covers insider trades and changes in ownership by company directors and executives.
2020-03-18 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a formal announcement of the submission of an audit report ('감사보고서 제출') by Kukje Pharma. It provides a summary of the audit opinion (unqualified/appropriate) and key financial data (assets, liabilities, revenue, profit/loss) for the fiscal year ending 2019-12-31. While it contains financial data, it is a regulatory filing announcing the completion and submission of the audit report to the exchange, rather than the full audit report document itself. Therefore, it is classified as a Report Publication Announcement (RPA). FY 2019
2020-03-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. It details the share acquisition (장내매수) by an executive (An Seok-hwan) of Kukje Pharma. This type of filing is specifically categorized as a 'Director's Dealing' (DIRS) report, as it documents personal share transactions by company insiders.
2020-02-28 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Kukje Pharma. It details the date, location, and agenda items for the upcoming Annual General Meeting, including the approval of financial statements, election of directors, and appointment of audit committee members. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting and the matters to be voted upon.
2020-02-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.